GALASSO, Gennaro
 Distribuzione geografica
Continente #
AS - Asia 12.700
NA - Nord America 7.501
EU - Europa 2.401
SA - Sud America 573
AF - Africa 81
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 8
Totale 23.280
Nazione #
HK - Hong Kong 9.325
US - Stati Uniti d'America 7.352
SG - Singapore 1.623
CN - Cina 720
VN - Vietnam 541
IT - Italia 540
RU - Federazione Russa 463
BR - Brasile 461
DE - Germania 369
UA - Ucraina 297
IE - Irlanda 195
FI - Finlandia 151
TR - Turchia 137
KR - Corea 134
SE - Svezia 99
GB - Regno Unito 87
CA - Canada 83
IN - India 56
AR - Argentina 45
MX - Messico 45
JP - Giappone 40
ES - Italia 39
PL - Polonia 37
ZA - Sudafrica 37
NL - Olanda 31
BD - Bangladesh 25
CZ - Repubblica Ceca 22
EC - Ecuador 19
FR - Francia 18
AT - Austria 16
ID - Indonesia 15
IQ - Iraq 15
EU - Europa 14
MA - Marocco 13
CO - Colombia 11
PY - Paraguay 10
UZ - Uzbekistan 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
IR - Iran 7
KE - Kenya 7
LT - Lituania 7
KZ - Kazakistan 6
LU - Lussemburgo 6
PK - Pakistan 6
AU - Australia 5
CH - Svizzera 5
IL - Israele 5
PE - Perù 5
SA - Arabia Saudita 5
BO - Bolivia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
EG - Egitto 3
NP - Nepal 3
PA - Panama 3
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
BB - Barbados 2
BY - Bielorussia 2
CR - Costa Rica 2
DZ - Algeria 2
GD - Grenada 2
GF - Guiana Francese 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
JO - Giordania 2
MY - Malesia 2
NE - Niger 2
NZ - Nuova Zelanda 2
OM - Oman 2
PH - Filippine 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
SV - El Salvador 2
TZ - Tanzania 2
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CL - Cile 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GN - Guinea 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
Totale 23.263
Città #
Hong Kong 9.322
Ann Arbor 1.442
Singapore 709
Chandler 682
Woodbridge 614
Dallas 541
Princeton 454
Jacksonville 438
Wilmington 408
Houston 358
Ashburn 335
Dong Ket 319
Munich 224
Dublin 193
Beijing 188
Boardman 124
Izmir 118
Los Angeles 115
Moscow 100
Salerno 95
Andover 91
Turku 91
Nanjing 88
Ho Chi Minh City 87
New York 87
Pellezzano 63
São Paulo 59
Naples 56
The Dalles 52
Columbus 48
Fairfield 46
Hanoi 44
Denver 38
Tokyo 38
Warsaw 35
Mestre 34
Montreal 30
Johannesburg 29
Nanchang 29
Seattle 29
Santa Clara 28
Poplar 26
Dearborn 25
Brooklyn 24
Changsha 24
Düsseldorf 24
Norwalk 23
Shenyang 23
Rome 21
Washington 21
Fisciano 20
Nuremberg 20
Stockholm 20
Falls Church 19
Jiaxing 19
Phoenix 19
San Francisco 19
Amsterdam 17
Mexico City 17
Orem 17
Boston 16
Brno 16
Chicago 16
Querétaro 16
Atlanta 15
Chennai 15
Hebei 15
Seoul 15
London 14
Rio de Janeiro 14
Manchester 13
Redwood City 13
Ankara 12
Belo Horizonte 12
Council Bluffs 12
Milan 12
Tianjin 12
Frankfurt am Main 11
Brasília 10
Haiphong 10
New Delhi 10
Sarno 10
Jinan 9
Porto Alegre 9
Charlotte 8
Da Nang 8
Domicella 8
Mumbai 8
San Diego 8
Tashkent 8
Vienna 8
Zhengzhou 8
Baghdad 7
Cambridge 7
Curitiba 7
Pune 7
Ribeirão Preto 7
Turin 7
Würselen 7
Dudelange 6
Totale 18.705
Nome #
No-Reflow Phenomenon: Pathophysiology, Diagnosis, Prevention, and Treatment. A Review of the Current Literature and Future Perspectives. 987
Clinical Characteristics and Outcomes of Patients With Takotsubo Syndrome and Left Ventricular Outflow Tract Obstruction 913
589 THE EFFECT OF DAPAGLIFLOZIN ON SYMPTOMS, QUALITY OF LIFE AND ECHOCARDIOGRAPHIC PARAMETERS IN A REAL-WORLD POPULATION OF HFREF PATIENTS 872
Abdominal Aortic Aneurysm: Natural History, Pathophysiology and Translational Perspectives 831
TRANSCATHETER IMPLANTABLE DEVICES TO MONITORING OF ELEVATED LEFT ATRIAL PRESSURES IN PATIENTS WITH CHRONIC HEART FAILURE 586
Plasma miR-1-3p levels predict severity in hospitalized COVID- 19 patients 526
Moving toward Precision Medicine in Acute Coronary Syndromes: A Multimodal Assessment of Non-Culprit Lesions 504
Artificial Intelligence in Hypertension Management: An Ace up Your Sleeve 438
Acute Coronary Syndrome in patients with SARS-CoV-2 infection: Pathophysiology and Translational Perspectives 422
An active lifestyle improves outcome of primary angioplasty in elderly patients with acute myocardial infarction. 406
Predictors of Recurrent Ischemic Events in Patients With ST-Segment Elevation Myocardial Infarction 400
[Diagnosis of cardiovascular involvement in Fabry disease] 379
Infective endocarditis and diabetes mellitus: Results from a single-center study from 1994 to 2017 352
Implantable cardioverter-defibrillator explosion after gunshot: When the device protects not only from arrhythmic death|Esplosione di defibrillatore impiantabile in seguito a colpo d’arma da fuoco: quando il defibrillatore non previene soltanto la morte aritmica 292
An innovative Olive Pâté with nutraceutical properties 276
Bivalirudin in Patients Undergoing PCI: State of Art and Future Perspectives 274
Exercise training and cardiac rehabilitation in covid-19 patients with cardiovascular complications: State of art 273
1-Year Outcomes With Intracoronary Abciximab in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention 271
COVID-19 and Acute Coronary Syndromes: From Pathophysiology to Clinical Perspectives 248
Technological Developments, Exercise Training Programs, and Clinical Outcomes in Cardiac Telerehabilitation in the Last Ten Years: A Systematic Review 232
Long-term clinical outcomes following sirolimus-eluting stent implantation in patients with acute myocardial infarction. A meta-analysis of randomized trials 225
The G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity by inducing nuclear accumulation of IkappaB alpha. 224
Importance of Echocardiography and Clinical "Red Flags" in Guiding Genetic Screening for Fabry Disease 219
Effects of physical activity on endothelial progenitor cells (EPCs) 215
Unrestricted use of endeavor resolute zotarolimus-eluting stent in daily clinical practice: a prospective registry 186
An active lifestyle prior to coronary surgery is associated with improved survival in elderly patients. 173
Analysis of regional right ventricular function by tissue doppler imaging in patients with aortic stenosis 170
Clinical outcome of patients with ST-elevation myocardial infarction and angiographic evidence of coronary artery ectasia 158
A new approach to percutaneous coronary revascularization in patients requiring undeferrable non-cardiac surgery. 154
Effect of an invasive strategy on outcome in patients ≥75 years of age with non-ST-elevation acute coronary syndrome 152
Relationship between changes in platelet reactivity and ischemic events following percutaneous coronary intervention: a meta-regression analysis of 30 randomized trials 152
Abciximab in elderly with acute coronary syndrome invasively treated: effect on outcome. 148
[Adipokines and coronary artery disease] 146
Twelve-month clinical outcomes of everolimus-eluting stent as compared to paclitaxel- and sirolimus-eluting stent in patients undergoing percutaneous coronary interventions. A meta-analysis of randomized clinical trials. 141
Reperfusion correlates and clinical outcomes of right ventricular dysfunction in patients with inferior ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention 139
Nobori biolimus-eluting stent vs. permanent polymer drug-eluting stents in patients undergoing percutaneous coronary intervention 137
Adiponectin promotes endothelial progenitor cell number and function 136
Valve-in-Valve Transcatheter Aortic Valve Replacement: From Pre-Procedural Planning to Procedural Scenarios and Possible Complications 136
Clinical profile and in-hospital outcome of Caucasian patients with takotsubo syndrome and right ventricular involvement 132
[Diabetes and ischemiccardiopathy] 131
β2-Adrenergic receptor stimulation improves endothelial progenitor cell-mediated ischemic neoangiogenesis 130
Global longitudinal strain predicts outcome after MitraClip implantation for secondary mitral regurgitation 124
Predictors of outcome in heart failure patients with severe functional mitral regurgitation undergoing MitraClip treatment 124
Antiplatelet versus anticoagulation therapy after extracardiac conduit Fontan: a systematic review and meta-analysis. 123
Pharmacotherapeutic considerations for the use of prasugrel and ticagrelor to reduce stent thrombosis in patients with acute coronary syndrome 123
Prior exercise improves age-dependent vascular endothelial growth factor downregulation and angiogenesis responses to hind-limb ischemia in old rats 120
Transradial versus transfemoral approach in patients undergoing percutaneous coronary intervention for acute coronary syndrome. A meta-analysis and trial sequential analysis of randomized controlled trials 118
Adenosine-induced torsade de pointes complicating a fractional flow reserve measurement in a right coronary artery intermediate stenosis. 117
Benefits from new ADP antagonists as compared with clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: A meta-analysis of randomized trials 117
Akt1/protein kinase Bα is critical for ischemic and VEGF-mediated angiogenesis 117
The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events. 114
[Is there an ideal stent for each type of coronarylesion?] 113
Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction 113
In concomitant coronary and peripheral arterial disease,inflammation of the affected limbs predicts coronary artery endothelial dysfunction. 110
Efficacy of automatic mode switching in DDDR mode pacemakers: The most 2 study 110
Arterial Hypertension in Patients with Takotsubo Syndrome: Prevalence, Long-Term Outcome, and Secondary Preventive Strategies. A Report from the Takotsubo Italian Network Register 109
Angiogenic-regulatory network revealed by molecular profiling heart tissue following Akt1 induction in endothelial cells 109
Multicentre experience with MGuard net protective stent in ST-elevation myocardial infarction: safety, feasibility, and impact on myocardial reperfusion. 105
Role of beta2 adrenergic receptors in human atherosclerotic coronary arteries. 105
Glucose control with insulin results in reduction of NF-kappaB-binding activity in mononuclear blood cells of patients with recently manifested type 1 diabetes 105
Effects of Ile164 polymorphism of beta2-adrenergic receptor gene on coronary artery disease. 104
Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation 104
Mortality reduction with transradial approach in patients with ST-segment elevation myocardial infarction: Is the randomized evidence conclusive? 103
Long-term safety and efficacy of drug-eluting stents in patients with acute myocardial infarction: a meta-analysis of randomized trials. 101
Relationship between contractile reserve, Tl-201 uptake, and collateral angiographic circulation in collateral-dependentmyocardium: implications regarding the evaluation of myocardial viability. 101
Prognostic value of clinical, echocardiographic and angiographic indicators in patients with large anterior ST-segment elevation myocardial infarction as a first acute coronary event 101
Impact of diabetes on cardiac sympathetic innervation in patients with heart failure: A 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic study 99
New perspectives for transcatheter aortic valve implantation: more than a "simple" alternative to surgery 98
Short-term Akt activation in cardiac muscle cells improves contractile function in failing hearts 98
Everolimus- versus first generation drug-eluting stents: the never-ending story of searching for a winner in the "limus family". 97
Coronary stenting early before non-cardiac surgery: is the endothelial progenitor cell capturing coronary stent a solution? 96
Intracoronary abciximab in diabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 96
Secondary Cardiovascular Prevention after Acute Coronary Syndrome: Emerging Risk Factors and Novel Therapeutic Targets 96
Rheolytic thrombectomy during percutaneous coronary interventionimproves long-term outcome in high-risk patients with acute myocardial infarction. 95
Reduction of lymphocyte G protein-coupled receptor kinase-2 (GRK2) after exercise training predicts survival in patients with heart failure 95
Precision and Personalized Medicine: How Genomic Approach Improves the Management of Cardiovascular and Neurodegenerative Disease 95
Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems 95
Intravenous antiplatelet therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 94
In vivo properties of the proangiogenic peptide QK. 94
Polymer-free versus biodegradable-polymer drug-eluting stent in patients undergoing percutaneous coronary intervention: an assessor-blind, non-inferiority, randomised controlled trial 93
Early stent thrombosis with bivalirudin in patients undergoing percutaneous coronary intervention: A meta-analysis of randomised clinical trials 93
Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction 93
Vitamin D deficiency is independently associated with the extent of coronary artery disease 93
Meta-analysis of randomized trials comparing the effectiveness of different strategies for the treatment of drug-eluting stent restenosis 92
Impact of bivaluridin and Genous stent in patients with acute myeloid leukemia undergoing emergency percutaneous coronary angioplasty for acute coronary syndrome 91
Increased inflammatory status and higher prevalence ofthree-vessel coronary artery disease in patients with concomitant coronary andperipheral atherosclerosis. 91
Sirolimus- versus paclitaxel-eluting stents in patients with acute myocardial infarction: a meta-analysis of randomized trials. 90
Endothelial dysfunction: Its clinical value and methods of assessment 89
Estimation of coronary flow reserve by Tc-99m sestamibi imaging in patients with coronary artery disease: comparison with the results of intracoronary Doppler technique 89
Clinical conditions and echocardiographic parameters associated with mortality in COVID-19 88
Endothelial alpha(1)-adrenoceptors regulate neo-angiogenesis. 88
Bioabsorbable drug-eluting vascular scaffold for the treatment of coronary in-stent restenosis: A two center registry 87
Insulin-like growth factor-1 protects from vascular stenosis and accelerates re-endothelialization in a rat model of carotid artery injury 87
Pooled Analysis Comparing the Efficacy of Intracoronary Versus Intravenous Abciximab in Smokers Versus Nonsmokers Undergoing Primary Percutaneous Coronary Revascularization for Acute ST-Elevation Myocardial Infarction 86
Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome 85
Exercise promotes angiogenesis and improves beta-adrenergic receptor signalling in the post-ischaemic failing rat heart. 85
Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. 84
Immediate and long-term outcome of recanalization of chronic total coronary occlusions. 84
Prognostic significance of the SYNTAX score and SYNTAX score II in patients with myocardial infarction treated with percutaneous coronary intervention 84
Impaired revascularization in a mouse model of type 2 diabetes is associated with dysregulation of a complex angiogenic-regulatory network 83
Totale 18.779
Categoria #
all - tutte 68.895
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.895


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021688 0 0 0 0 88 19 77 9 70 8 75 342
2021/2022819 1 1 2 7 41 25 32 40 103 99 97 371
2022/20231.561 145 135 49 192 213 319 2 139 270 7 60 30
2023/2024809 99 114 52 28 54 104 19 38 5 36 32 228
2024/20252.549 61 33 41 117 90 232 429 136 357 160 483 410
2025/202612.979 3.391 3.878 3.469 730 1.511 0 0 0 0 0 0 0
Totale 23.632